Forschungskolloquium für Wissenschaftler:innen, Studierende und Interessierte (auf Englisch) / Research colloquium for scientists, students and interested parties (in English)
Vorträge über Neuroimaging, Computational Psychiatry und neue Entwicklungen von etablierten Forscher:innen aus anderen deutschen und internationalen Universitäten.
Die Vorträge sind in englischer Sprache und finden in der Regel einmal im Monat am Donnerstag um 15:00 Uhr statt.
Nähere Informationen sowie Zoom-Zugangsdaten erhalten Sie per Ankündigung, auf unserer Homepage oder auf Nachfrage
Lectures on neuroimaging, computational psychiatry and new developments by established researchers from other German and
international universities.
The lectures are in English and take place once a month on Thursdays at 15:00.
You will receive further information and Zoom access data by announcement, on our homepage or on request
Next Talk:
Monday, March 17th, 2025, 03:00 pm
Dear colleagues,
We are pleased to announce the next speaker for our "Research Colloquium" at the Department of Psychiatry and Psychotherapy in Jena, which will take place as a hybrid event. Please note that the talk will be held on a Monday this time at 15:00 in the lecture hall.
Speaker:
Translational Neuroscience at BIDMC, Harvard Medical School, Boston, USA
Title:
Bridging Retinal Imaging, Biomarkers, and Neuromodulation: Advancing Precision Interventions for Psychosis Spectrum Disorders
Date and Time:
Monday, March 17th, 2025, 03:00 pm
Location:
Lecture Hall, Department of Psychiatry and Psychotherapy and via zoom.
Additional zoom access data (constantly equal):
https://uni-jena-de.zoom.us/j/69357966003
Meeting ID: 693 5796 6003
ID code: talk
Dr. Paulo Lizano serves as an Assistant Professor of Psychiatry at Harvard Medical School and is the Division Chief of Translational Neuroscience at Beth Israel DeaconessMedical Center, where he also directs the ASPIRE clinic for early psychosis. His research focuses on understanding the inflammatory and microvascular underpinnings of psychosis. He employs techniques such as retinal and brain imaging, blood-based biomarker analysis, and neuromodulation to identify novel biomarkers and potential treatment targets for psychotic disorders. In addition to his research and clinical roles, Dr. Lizano is committed to advancing mental health care through education and advocacy. He has received multiple awards and grants from NIH supporting his work in psychosis and related fields.
Bridging Retinal Imaging, Biomarkers, and Neuromodulation: Advancing Precision Interventions for Psychosis Spectrum Disorders
I focus on utilizing retinal/brain imaging, blood-based biomarker technology, and neuromodulation to better characterize and offer more personalized and targeted interventions to individuals with psychosis spectrum disorders. I actively develop retinal and brain imaging processing tools and blood-based biomarker subtyping to parse the heterogeneity in psychosis. My work also involves bridging in vivo and ex vivo techniques to examine inflammation-mediated disruption of the blood brain barrier in psychosis. I have expertise in non-invasive neuromodulation to target causal brain regions in the extrastriate visual cortex or superior temporal sulcus that are associated with visual hallucinations and overall hallucinations respectively.
Feel free to share this announcement with colleagues, staff and students!
Best regards,
Christian Gaser